<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR52036</article-id>
      <title-group>
        <article-title>Hepatitis B immunity status of Biomedical Students in Usmanu Danfodiyo University Sokoto, North Western Nigeria.</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>AN</surname>
            <given-names>Okwesili</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jafaru</surname>
            <given-names>Hassan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>O</surname>
            <given-names>Erhabor</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Y</surname>
            <given-names>Abdulrhaman</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>EK</surname>
            <given-names>Uko</given-names>
          </name>
          <xref ref-type="aff" rid="aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>F</surname>
            <given-names>Udomah</given-names>
          </name>
          <xref ref-type="aff" rid="aff3"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Faculty of Medical Laboratory Science, Department of Haematology and Blood Transfusion Science, Usmanu Danfodiyo University Sokoto, Nigeria.</aff>
      <aff id="aff2">Department of Haematology, University of Calabar Nigeria.</aff>
      <aff id="aff3">Department of Haematology, University of Calabar Teaching Hospital, Calabar, Nigeria.</aff>
      <pub-date pub-type="epub" iso-8601-date="2015-04-01">
        <month>04</month>
        <day>01</day>
        <year>2015</year>
      </pub-date>
      <volume>5</volume>
      <issue>2</issue>
      <abstract>
        <p>The aim of this study was to investigate the Hepatitis B immunity status of Biomedical Students of Usmanu Danfodiyo University Sokoto, North-Western Nigeria. CTK Biotech (USA) Onsite HBsAb ELISA kit was used for the determination of HBsAb status of subjects. We investigated the HBsAb status of 186 biomedical students aged ≥ 18 years (mean age 26 ± 2.0 years) made up of 147 males and 39 females. Out of 186 subject analyzed, 69 (37.1%) were Medical, 75(40.3%) were Medical Laboratory Science and 42(22.6%) were Nursing students. Age group distribution among these subject shows that majority 108(58.0%) were in the 21-25 years age group. Subjects were stratified based on marital status. Majority of subjects were single 173(93.1%) compared to married 13 (6.9%). Ethnic distribution of subjects indicated that 104(55.9%) were Hausa, 32 (17.2%) were Yoruba while 20(10.8%), 9(4.8%) and 21(11.3%) were Fulani, Igbo and other ethnic groups respectively. Among the 186 subjects studied, only 13(7.0%) has had prior complete course of hepatitis B vaccination (p=0.001). Protective HBsAb titre (&gt;10miu/ml) was evident in 72(38.7%) of the subjects while 114 (61.3%) did not had no protective HBsAb titre (</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Hepatitis B immunity status</kwd>
        <kwd>Biomedical Students</kwd>
        <kwd>Usmanu Danfodiyo University</kwd>
        <kwd>Nigeria.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
